This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of pembrolizumab monotherapy versus chemotherapy for the second-line treatment of advanced urothelial carcinoma.
Bibliographical notePublisher Copyright:
© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
All Science Journal Classification (ASJC) codes
- Pharmacology (medical)